Requirement for BAFF and APRIL during B cell development in GALT

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5527-5536

  Yeramilli, Venkata A ^a   Knight, Katherine L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; LIGAND;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; BONE MARROW; CELL PROLIFERATION; CONTROLLED STUDY; INTESTINE LYMPHATIC TISSUE; LYMPHOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; AGING; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; CHO CELL; CRICETULUS; CYTOLOGY; GASTROINTESTINAL TRACT; GENETICS; HAMSTER; HUMAN; IMMUNOLOGY; LYMPHOID TISSUE; METABOLISM; NEWBORN; PHYSIOLOGY;

AGING; ANIMALS; ANIMALS, NEWBORN; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTE SUBSETS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; GASTROINTESTINAL TRACT; HUMANS; LIGANDS; LYMPHOID TISSUE; LYMPHOPOIESIS; RABBITS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 77954751958     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000146     Document Type: Article

References (61)

1. Schneider, P., F. MacKay, V. Steiner, K. Hofmann, J. L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, et al. 1999. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189: 1747-1756.
2. Thompson, J. S., S. A. Bixler, F. Qian, K. Vora, M. L. Scott, T. G. Cachero, C. Hession, P. Schneider, I. D. Sizing, C. Mullen, et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293: 2108-2111.
3. Gross, J. A., J. Johnston, S. Mudri, R. Enselman, S. R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999.
4. Thompson, J. S., P. Schneider, S. L. Kalled, L. Wang, E. A. Lefevre, T. G. Cachero, F. MacKay, S. A. Bixler, M. Zafari, Z. Y. Liu, et al. 2000. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192: 129-135.
5. Hahne, M., T. Kataoka, M. Schröter, K. Hofmann, M. Irmler, J. L. Bodmer, P. Schneider, T. Bornand, N. Holler, L. E. French, et al. 1998. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188: 1185-1190.
6. Wu, Y., D. Bressette, J. A. Carrell, T. Kaufman, P. Feng, K. Taylor, Y. Gan, Y. H. Cho, A. D. Garcia, E. Gollatz, et al. 2000. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 275: 35478-35485.
7. Yu, G., T. Boone, J. Delaney, N. Hawkins, M. Kelley, M. Ramakrishnan, S. McCabe, W. R. Qiu, M. Kornuc, X. Z. Xia, et al. 2000. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity. Nat. Immunol. 1: 252-256.
8. Schiemann, B., J. L. Gommerman, K. Vora, T. G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M. L. Scott. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293: 2111-2114. (Pubitemid 32848063)
9. Gross, J. A., S. R. Dillon, S. Mudri, J. Johnston, A. Littau, R. Roque, M. Rixon, O. Schou, K. P. Foley, H. Haugen, et al. 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15: 289-302.
10. Yan, M., H. Wang, B. Chan, M. Roose-Girma, S. Erickson, T. Baker, D. Tumas, I. S. Grewal, and V. M. Dixit. 2001. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2: 638-643.
11. Varfolomeev, E., F. Kischkel, F. Martin, D. Seshasayee, H. Wang, D. Lawrence, C. Olsson, L. Tom, S. Erickson, D. French, et al. 2004. APRIL-deficient mice have normal immune system development. Mol. Cell. Biol. 24: 997-1006.
12. Castigli, E., S. Scott, F. Dedeoglu, P. Bryce, H. Jabara, A. K. Bhan, E. Mizoguchi, and R. S. Geha. 2004. Impaired IgA class switching in APRILdeficient mice. Proc. Natl. Acad. Sci. USA 101: 3903-3908.
13. O'Connor, B. P., V. S. Raman, L. D. Erickson, W. J. Cook, L. K. Weaver, C. Ahonen, L. L. Lin, G. T. Mantchev, R. J. Bram, and R. J. Noelle. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199: 91-98.
14. Salzer, U., H. M. Chapel, A. D. Webster, Q. Pan-Hammarström, A. Schmitt-Graeff, M. Schlesier, H. H. Peter, J. K. Rockstroh, P. Schneider, A. A. Schäffer, et al. 2005. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37: 820-828.
15. Salzer, U., C. Bacchelli, S. Buckridge, Q. Pan-Hammarström, S. Jennings, V. Lougaris, A. Bergbreiter, T. Hagena, J. Birmelin, A. Plebani, et al. 2009. Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood 113: 1967-1976.
16. Warnatz, K., U. Salzer, M. Rizzi, B. Fischer, S. Gutenberger, J. Bohm, A. K. Kienzler. Q. Pan-Hammarström, L. Hammarström, M. Rakhmanov, et al. 2009. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci USA 106: 13945-13950.
17. Schneider, K., S. Kothlow, P. Schneider, A. Tardivel, T. Göbel, B. Kaspers, and P. Staeheli. 2004. Chicken BAFF - a highly conserved cytokine that mediates B cell survival. Int. Immunol. 16: 139-148.
18. Guan, Z. B., J. L. Ye, W. B. Dan, W. J. Yao, and S. Q. Zhang. 2007. Cloning, expression and bioactivity of duck BAFF. Mol. Immunol. 44: 1471-1476.
19. Chen, C. M., W. H. Ren, G. Yang, C. S. Zhang, and S. Q. Zhang. 2009. Molecular cloning, in vitro expression and bioactivity of quail BAFF. Vet. Immunol. Immunopathol. 130: 125-130.
20. Guan, Z. B., W. B. Dan, Y. Shui, J. L. Ye, and S. Q. Zhang. 2007. cDNA cloning, expression and bioactivity of porcine BAFF. Dev. Comp. Immunol. 31: 1211-1219.
21. Guan, Z. B., Y. Shui, and S. Q. Zhang. 2007. Two related ligands of the TNF family, BAFF and APRIL, in rabbit: molecular cloning, 3D modeling, and tissue distribution. Cytokine 39: 192-200.
22. Reddy, S. K., T. Hu, R. Gudivada, K. A. Staines, K. E. Wright, L. Vickerstaff, S. Kothlow, L. G. Hunt, C. Butter, B. Kaspers, and J. R. Young. 2008. The BAFF-Interacting receptors of chickens. Dev. Comp. Immunol. 32: 1076-1087.
23. Kothlow, S., I. Morgenroth, Y. Graef, K. Schneider, I. Riehl, P. Staeheli, P. Schneider, and B. Kaspers. 2007. Unique and conserved functions of B cellactivating factor of the TNF family (BAFF) in the chicken. Int. Immunol. 19: 203-215.
24. Weinstein, P. D., A. O. Anderson, and R. G. Mage. 1994. Rabbit IgH sequences in appendix germinal centers: VH diversification by gene conversion-like and hypermutation mechanisms. Immunity 1: 647-659.
25. Reynaud, C. A., C. R. Mackay, R. G. Müller, and J. C. Weill. 1991. Somatic generation of diversity in a mammalian primary lymphoid organ: the sheep ileal Peyer's patches. Cell 64: 995-1005.
26. Meyer, A., C. L. Parng, S. A. Hansal, B. A. Osborne, and R. A. Goldsby. 1997. Immunoglobulin gene diversification in cattle. Int. Rev. Immunol. 15: 165-183.
27. Parng, C. L., S. Hansal, R. A. Goldsby, and B. A. Osborne. 1996. Gene conversion contributes to Ig light chain diversity in cattle. J. Immunol. 157: 5478-5486.
28. Butler, J. E., J. Sun, P. Weber, P. Navarro, and D. Francis. 2000. Antibody repertoire development in fetal and newborn piglets, III. Colonization of the gastrointestinal tract selectively diversifies the preimmune repertoire in mucosal lymphoid tissues. Immunology 100: 119-130.
29. Weinstein, P. D., R. G. Mage, and A. O. Anderson. 1994. The appendix functions as a mammalian bursal equivalent in the developing rabbit. Adv. Exp. Med. Biol. 355: 249-253.
30. Crane, M. A., C. Raman, and K. L. Knight. 1993. An expanded view of the ontogeny of the rabbit humoral immune system. Res. Immunol. 144: 486-491.
31. Knight, K. L., and M. A. Crane. 1994. Generating the antibody repertoire in rabbit. Adv. Immunol. 56: 179-218.
32. Lanning, D., X. Zhu, S. K. Zhai, and K. L. Knight. 2000. Development of the antibody repertoire in rabbit: gut-associated lymphoid tissue, microbes, and selection. Immunol. Rev. 175: 214-228.
33. Rhee, K. J., P. Sethupathi, A. Driks, D. K. Lanning, and K. L. Knight. 2004. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 172: 1118-1124.
34. Cooper, M. D., D. Y. Perey, A. E. Gabrielsen, D. E. Sutherland, M. F. McKneally, and R. A. Good. 1968. Production of an antibody deficiency syndrome in rabbits by neonatal removal of organized intestinal lymphoid tissues. Int. Arch. Allergy Appl. Immunol. 33: 65-88.
35. Vajdy, M., P. Sethupathi, and K. L. Knight. 1998. Dependence of antibody somatic diversification on gut-associated lymphoid tissue in rabbits. J. Immunol. 160: 2725-2729.
36. Crane, M. A., M. Kingzette, and K. L. Knight. 1996. Evidence for limited Blymphopoiesis in adult rabbits. J. Exp. Med. 183: 2119-2121.
37. Jasper, P. J., S. K. Zhai, S. L. Kalis, M. Kingzette, and K. L. Knight. 2003. B lymphocyte development in rabbit: progenitor B cells and waning of B lymphopoiesis. J. Immunol. 171: 6372-6380.
38. Yang, J., R. Pospisil, and R. G. Mage. 2009. Expression and localization of rabbit B-cell activating factor (BAFF) and its specific receptor BR3 in cells and tissues of the rabbit immune system. Dev. Comp. Immunol. 33: 697-708.
39. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
40. Hanson, N. B., and D. K. Lanning. 2008. Microbial induction of B and T cell areas in rabbit appendix. Dev. Comp. Immunol. 32: 980-991.
41. Nardelli, B., O. Belvedere, V. Roschke, P. A. Moore, H. S. Olsen, T. S. Migone, S. Sosnovtseva, J. A. Carrell, P. Feng, J. G. Giri, and D. M. Hilbert. 2001. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97: 198-204.
42. Sethupathi, P., H. Spieker-Polet, H. Polet, P. C. Yam, C. Tunyaplin, and K. L. Knight. 1994. Lymphoid and non-lymphoid tumors in E kappa-myc transgenic rabbits. Leukemia 8: 2144-2155.
43. Knight, K. L., H. Spieker-Polet, D. S. Kazdin, and V. T. Oi. 1988. Transgenic rabbits with lymphocytic leukemia induced by the c-myc oncogene fused with the immunoglobulin heavy chain enhancer. Proc. Natl. Acad. Sci. USA 85: 3130-3134.
44. Darce, J. R., B. K. Arendt, S. K. Chang, and D. F. Jelinek. 2007. Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J. Immunol. 178: 5612-5622.
45. Li, X., K. Su, C. Ji, A. J. Szalai, J. Wu, Y. Zhang, T. Zhou, R. P. Kimberly, and J. C. Edberg. 2008. Immune opsonins modulate BLyS/BAFF release in a receptor- specific fashion. J. Immunol. 181: 1012-1018.
46. Chu, V. T., P. Enghard, G. Riemekasten, and C. Berek. 2007. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J. Immunol. 179: 5947-5957.
47. Avery, D. T., S. L. Kalled, J. I. Ellyard, C. Ambrose, S. A. Bixler, M. Thien, R. Brink, F. Mackay, P. D. Hodgkin, and S. G. Tangye. 2003. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112: 286-297.
48. He, B., A. Chadburn, E. Jou, E. J. Schattner, D. M. Knowles, and A. Cerutti. 2004. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 172: 3268-3279. (Pubitemid 38263719)
49. Ritter,M. R., E. Banin, S. K. Moreno, E.Aguilar, M. I. Dorrell, and M. Friedlander. 2006. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J. Clin. Invest. 116: 3266-3276.
50. Kanswal, S., N. Katsenelson, A. Selvapandiyan, R. J. Bram, and M. Akkoyunlu. 2008. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL. J. Immunol. 181: 976-990.
51. Won, W. J., and J. F. Kearney. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168: 5605-5611.
52. Mackay, F., and P. Schneider. 2009. Cracking the BAFF code. Nat. Rev. Immunol. 9: 491-502.
53. Meyer-Bahlburg, A., S. F. Andrews, K. O. Yu, S. A. Porcelli, and D. J. Rawlings. 2008. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J. Exp. Med. 205: 155-168.
54. Batten, M., J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning, and F. Mackay. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192: 1453-1466.
55. Badr, G., G. Borhis, E. A. Lefevre, N. Chaoul, F. Deshayes, V. Dessirier, G. Lapree, A. Tsapis, and Y. Richard. 2008. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 111: 2744-2754.
56. Khan, W. N. 2009. B cell receptor and BAFF receptor signaling regulation of B cell homeostasis. J. Immunol. 183: 3561-3567.
57. Carter, R. H., H. Zhao, X. Liu, M. Pelletier, W. Chatham, R. Kimberly, and T. Zhou. 2005. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus. Arthritis Rheum. 52: 3943-3954.
58. Zhang, J., V. Roschke, K. P. Baker, Z. Wang, G. S. Alarcón, B. J. Fessler, H. Bastian, R. P. Kimberly, and T. Zhou. 2001. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166: 6-10.
59. Mariette, X., S. Roux, J. Zhang, D. Bengoufa, F. Lavie, T. Zhou, and R. Kimberly. 2003. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann. Rheum. Dis. 62: 168-171.
60. Cheema, G. S., V. Roschke, D. M. Hilbert, and W. Stohl. 2001. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44: 1313-1319.
61. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710.